Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, VivoSim Labs Inc’s stock clocked out at $1.95, up 1.56% from its previous closing price of $1.92. In other words, the price has increased by $1.56 from its previous closing price. On the day, 1.18 million shares were traded.
Ratios:
To gain a deeper understanding of VIVS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.72 and its Current Ratio is at 0.72. In the meantime, Its Debt-to-Equity ratio is 3.67 whereas as Long-Term Debt/Eq ratio is at 1.50.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 13, 2018, initiated with a Buy rating and assigned the stock a target price of $2.50.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 27.68 while its Price-to-Book (P/B) ratio in mrq is 7.65.
Stock Price History:
Over the past 52 weeks, VIVS has reached a high of $21.96, while it has fallen to a 52-week low of $1.56. The 50-Day Moving Average of the stock is -42.76%, while the 200-Day Moving Average is calculated to be -60.90%.
Shares Statistics:
A total of 1.70M shares are outstanding, with a floating share count of 1.67M. Insiders hold about 1.67% of the company’s shares, while institutions hold 12.12% stake in the company.
